Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health. The company currently has two commercial products: VASCAZEN® is available in the US by prescription only and OMAZEN™ is available for sale as a natural health product in Canada.The company's lead product VASCAZEN® is a prescription only Medical Food for the treatment of an Omega-3 Deficiency (OM3D) in patients with cardiovascular disease. The company's second product OMAZEN® is an ultra pure Omega-3 for the maintenance of good health.
Pivotal Therapeutics Inc. (PVO)
October 23, 2017
The common shares of Pivotal Therapeutics Inc. will be delisted at the market close today, October 23, 2017.
Pivotal Therapeutics is currently suspended.
Date: Market close, October 23, 2017